ARCHIVES

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

In Brief: More Than 1,600 Taking First Oncology Nurse Certification Exam; FCC Discussions Planned

April 4, 1986

Women’s Health Trial Committee Hears New Analysis Of Vanguard Groups, Other Data

January 1, 1988

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

Virus Program Report On Scientific Activities

August 15, 1975